Don’t prescribe a medication without conducting a drug regimen review (medication reconciliation)

Type of practice

Drugs

Topic Area

Geriatrics

The prevalence of polypharmacy in old age (commonly defined as the use of 5 or more drugs) is on the rise in high income countries. In Italy, the proportion of people 65 years of age and older prescribed five or more medications rose from 43% to 53% between 2000 and 2010. Risk of iatrogenic harm increases with the number of medications and approximately 10% of hospital admissions in the elderly are due to adverse drug reactions. Polypharmacy has been linked to a broad range of negative health outcomes, including lack of therapeutic adherence, increased risk of cognitive and functional impairment, worsening of falls. The Medication Reconciliation Process in elderly people, especially when a new drug is going to be started, is an essential tool for underprescribing and overprescribing evaluation, including potential drug interactions. A drug regimen review should deserve special attention in people with a limited remaining life expectancy.

Sources

1. American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227–2246.
2. O’Mahony D, O’Sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–218.
3. Jonas W. Wastesson, Lucas Morin, Edwin C.K. Tan & Kristina Johnell (2018): An update on the clinical consequences of polypharmacy in older adults: a narrative review, Expert Opinion on Drug Safety, DOI: 10.1080/14740338.2018.1546841
4. American Geriatrics Society. Ten Things Physicians and Patients Should Question. www.americangeriatrics.org.

Download

PDF

Attention. Please note that these items are provided only for information and are not intended as a substitute for consultation with a clinician. Patients with any specific questions about the items on this list or their individual situation should consult their clinician.